Athenex Pharmaceuticals

Cyclophosphamide

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Cyclophosphamide – J9070

Manufacturer:

Athenex Pharmaceuticals

Name:

Cyclophosphamide

HCPCS Code Descriptor:

Cyclophosphamide, 100 mg

Category:

J Code

HCPCS:

J9070

NDC(s):

72603-0326-01, 72603-0104-01, 72572-0087-01, 72572-0085-01, 72572-0083-01, 70860-0218-05, 70860-0218-10, 70860-0218-03, 70121-1240-01, 70121-1238-01, 70121-1239-01, 68001-0565-28, 68001-0564-22, 68001-0442-26, 68001-0443-27, 68001-0444-32, 50742-0521-10, 50742-0519-02, 50742-0520-05, 16714-0858-01, 16714-0859-01, 16714-0857-01, 10019-0957-01, 10019-0956-01, 10019-0955-01, 10019-0938-01, 10019-0939-01, 10019-0942-01, 10019-0943-01, 10019-0944-01, 10019-0945-01, 10019-0937-01, 10019-0935-01, 10019-0936-01, 00781-3255-94, 00781-3244-94, 00781-3233-94

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

Cyclophosphamide is an Oncology drug manufactured by Athenex Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9070 is aligned to the drug Cyclophosphamide.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/84

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Cyclophosphamide 100 mg inj

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found